Evidence map›Paper›PMID 21159255›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2010

[Expressions and significances of PRL-3 and RhoC in A549 cell].

Ping ZHANG, Zhipei ZHANG, Xiangmin LI, Jie LEI, Kai SU, Xiaofei LI, Xiaoping WANG

Abstract read
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ping ZHANGDepartment of Thoracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, China.
Zhipei ZHANG
Xiangmin LI
Jie LEI
Kai SU
Xiaofei LI
Xiaoping WANG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivethe expression of phosphatase of regenerating liver-3 (PRL-3) is correlated with Ras homologue C (RhoC) in non-small cell lung cancer (NSCLC), suggesting that they have interactions. The aim of this study is to investigate the functions of PRL-3 and RhoC in the migration of A549 cell and the potential mechanism of PRL-3 and RhoC in carcinogenesis and cancer development..

methodsPRL-3Ab and RhoCAb were used to block the functions of PRL-3 and RhoC respectively. Wound healing assay was applied to detect the migration of A549 cell and the expression levels of PRL-3 and RhoC were detected by RT-PCR.

resultsthe migration of A549 cell decreased after blockage of PRL-3 and RhoC. The expression of RhoC decreased when PRL-3 was blocked without any changes on the expression of PRL-3.

conclusionsPRL-3, RhoC could increase cell migration in A549 cells.

Indexed as

AntibodiesCell Line, TumorCell MovementHumansLung NeoplasmsNeoplasm ProteinsProtein Tyrosine PhosphatasesReverse Transcriptase Polymerase Chain ReactionrhoC GTP-Binding Proteinrho GTP-Binding ProteinsAntibodiesNeoplasm ProteinsProtein Tyrosine PhosphatasesPTP4A3 protein, humanrhoC GTP-Binding ProteinRHOC protein, humanrho GTP-Binding Proteins

Identifiers

PMID21159255
PMCPMC6426730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.